TABLE OF CONTENTS
|  |  |  | Volume 35, Issue 16 (April 2016) |  | In this issue Review Original Articles
Also new    AOP | |  |  |  | Advertisement |  | Oncogenesis Focus Collection: Cancer & Metabolism
While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells.
Explore the complete Special Issue in full. |  | | |  |  | Review | Top |  | Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkersH Wang, L Liang, J-Y Fang and J Xu Oncogene 2016 35: 2011-2019; advance online publication, August 10, 2015; 10.1038/onc.2015.304 Abstract | Full Text |  | Original Articles | Top |  | Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma OPENS Satheesha, G Manzella, A Bovay, E A Casanova, P K Bode, R Belle, S Feuchtgruber, P Jaaks, N Dogan, E Koscielniak and B W Schäfer Oncogene 2016 35: 2020-2030; advance online publication, July 20, 2015; 10.1038/onc.2015.267 Abstract | Full Text |  |  |  | Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cellsS Calabretta, P Bielli, I Passacantilli, E Pilozzi, V Fendrich, G Capurso, G Delle Fave and C Sette Oncogene 2016 35: 2031-2039; advance online publication, August 3, 2015; 10.1038/onc.2015.270 Abstract | Full Text |  |  |  | KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2L Jia, Z Zhou, H Liang, J Wu, P Shi, F Li, Z Wang, C Wang, W Chen, H Zhang, Y Wang, R Liu, J Feng and C Chen Oncogene 2016 35: 2040-2051; advance online publication, July 20, 2015; 10.1038/onc.2015.263 Abstract | Full Text |  |  |  | BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastomaJ Hagenbuchner, U Kiechl-Kohlendorfer, P Obexer and M J Ausserlechner Oncogene 2016 35: 2052-2061; advance online publication, July 6, 2015; 10.1038/onc.2015.264 Abstract | Full Text |  |  |  | E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60V K Subbaiah, Y Zhang, D Rajagopalan, L N Abdullah, N S L Yeo-Teh, V Tomaić, L Banks, M P Myers, E K Chow and S Jha Oncogene 2016 35: 2062-2074; advance online publication, August 3, 2015; 10.1038/onc.2015.268 Abstract | Full Text |  |  |  | The EGF receptor ligand amphiregulin controls cell division via FoxM1S W Stoll, P E Stuart, W R Swindell, L C Tsoi, B Li, A Gandarillas, S Lambert, A Johnston, R P Nair and J T Elder Oncogene 2016 35: 2075-2086; advance online publication, August 3, 2015; 10.1038/onc.2015.269 Abstract | Full Text |  |  |  | Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1P Phatak, K A Byrnes, D Mansour, L Liu, S Cao, R Li, J N Rao, D J Turner, J-Y Wang and J M Donahue Oncogene 2016 35: 2087-2097; advance online publication, August 3, 2015; 10.1038/onc.2015.271 Abstract | Full Text |  |  |  | Regulation of sarcoma cell migration, invasion and invadopodia formation by AFAP1L1 through a phosphotyrosine-dependent pathwayS R Tie, D J McCarthy, T S Kendrick, A Louw, C Le, J Satiaputra, N Kucera, M Phillips and E Ingley Oncogene 2016 35: 2098-2111; advance online publication, July 27, 2015; 10.1038/onc.2015.272 Abstract | Full Text |  |  |  | Disrupting Na+,HCO3–-cotransporter NBCn1 (Slc4a7) delays murine breast cancer developmentS Lee, T V Axelsen, A P Andersen, P Vahl, S F Pedersen and E Boedtkjer Oncogene 2016 35: 2112-2122; advance online publication, July 27, 2015; 10.1038/onc.2015.273 Abstract | Full Text |  |  |  | CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancerY-C Wu, S-J Tang, G-H Sun and K-H Sun Oncogene 2016 35: 2123-2132; advance online publication, July 27, 2015; 10.1038/onc.2015.274 Abstract | Full Text |  |  |  | Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer developmentW Yang, M T S Mok, M S M Li, W Kang, H Wang, A W Chan, J-L Chou, J Chen, E K W Ng, K-F To, J Yu, M W Y Chan, F K L Chan, J J Y Sung and A S L Cheng Oncogene 2016 35: 2133-2144; advance online publication, July 27, 2015; 10.1038/onc.2015.276 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | |
No comments:
Post a Comment